Cargando…

Photodynamic Therapy for Eye Cancer

Photodynamic therapy is well-established as a treatment for a number of conditions in ophthalmology, principally in the field of medical retina, but less so in ocular oncology. Cancer of the eye is rare, the commonest lesions to affect the globe being choroidal melanoma (as a primary malignancy) and...

Descripción completa

Detalles Bibliográficos
Autor principal: Rundle, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744093/
https://www.ncbi.nlm.nih.gov/pubmed/29292745
http://dx.doi.org/10.3390/biomedicines5040069
_version_ 1783288684631556096
author Rundle, Paul
author_facet Rundle, Paul
author_sort Rundle, Paul
collection PubMed
description Photodynamic therapy is well-established as a treatment for a number of conditions in ophthalmology, principally in the field of medical retina, but less so in ocular oncology. Cancer of the eye is rare, the commonest lesions to affect the globe being choroidal melanoma (as a primary malignancy) and choroidal metastases (a secondary malignancy). The mainstay of treatment of such lesions remains radiotherapy in various forms, however, photodynamic therapy does have a useful role to play in the management of such patients. In this article, I hope to review the current indications, treatment regimes, and the risks and benefits of photodynamic therapy (PDT) as a treatment for eye cancer.
format Online
Article
Text
id pubmed-5744093
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57440932017-12-31 Photodynamic Therapy for Eye Cancer Rundle, Paul Biomedicines Review Photodynamic therapy is well-established as a treatment for a number of conditions in ophthalmology, principally in the field of medical retina, but less so in ocular oncology. Cancer of the eye is rare, the commonest lesions to affect the globe being choroidal melanoma (as a primary malignancy) and choroidal metastases (a secondary malignancy). The mainstay of treatment of such lesions remains radiotherapy in various forms, however, photodynamic therapy does have a useful role to play in the management of such patients. In this article, I hope to review the current indications, treatment regimes, and the risks and benefits of photodynamic therapy (PDT) as a treatment for eye cancer. MDPI 2017-12-08 /pmc/articles/PMC5744093/ /pubmed/29292745 http://dx.doi.org/10.3390/biomedicines5040069 Text en © 2017 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Rundle, Paul
Photodynamic Therapy for Eye Cancer
title Photodynamic Therapy for Eye Cancer
title_full Photodynamic Therapy for Eye Cancer
title_fullStr Photodynamic Therapy for Eye Cancer
title_full_unstemmed Photodynamic Therapy for Eye Cancer
title_short Photodynamic Therapy for Eye Cancer
title_sort photodynamic therapy for eye cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744093/
https://www.ncbi.nlm.nih.gov/pubmed/29292745
http://dx.doi.org/10.3390/biomedicines5040069
work_keys_str_mv AT rundlepaul photodynamictherapyforeyecancer